Simple Summary Cutaneous squamous cell carcinoma (cSCC) is an increasingly prevalent
and morbid cancer worldwide. Management of this cancer has changed significantly in the …

Aim: To estimate the comparative efficacy of cemiplimab, a programmed cell death protein 1
inhibitor, versus EGFR inhibitors, pembrolizumab and platinum-based chemotherapy in …

The NCCN Guidelines for Squamous Cell Skin Cancer provide recommendations for
diagnostic workup, clinical stage, and treatment options for patients with cutaneous …

Purpose This guideline reviews the evidence for the use of definitive and postoperative
radiation therapy (RT) in patients with basal cell carcinoma (BCC) and cutaneous squamous …

Considering the rising incidence, cutaneous squamous‐cell carcinoma (cSCC) has a high
clinical relevance. In patients with localized cSCC, complete surgical resection is indicated …

Keratinocyte cancers–basal and cutaneous squamous cell carcinoma (BCC, cSCC)–are the
most common forms of non-melanoma skin cancer (NMSC) and there has been a significant …

One in twenty solid organ transplant recipients (SOTRs) will develop a highly morbid or fatal
cutaneous carcinoma after transplantation. The majority of these cases develop on the head …

Cutaneous squamous cell carcinomas (cSCC) represent one of the most diagnosed non-
melanoma skin cancers and its incidence is increasing globally. Whereas early stage and …

The management of head and neck cancer is complex and often involves multimodality
treatment. Certain groups of patients, such as those with inoperable or advanced disease …

Solid organ transplant recipients (SOTRs) are particularly prone to developing
malignancies, often manifesting multiple tumors and tumors with a heightened susceptibility …